Brolucizumab for treating neovascular age-related macular degeneration: An alternative for treatment-refractory patients

Martin Biilmann Groen^*, Anders Højslet Vestergaard, Lasse Jørgensen Cehofski

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate › Research › peer-review

Documents & Links

@article{60afde93e7a7473a922f278555a76357,

title = "Brolucizumab for treating neovascular age-related macular degeneration: An alternative for treatment-refractory patients",

author = "Groen, {Martin Biilmann} and Vestergaard, {Anders H{\o}jslet} and Cehofski, {Lasse J{\o}rgensen}",

year = "2025",

month = jan,

day = "21",

doi = "10.1111/aos.17446",

language = "English",

journal = "Acta Ophthalmologica",

issn = "1755-375X",

publisher = "Wiley",

}

TY - JOUR

T1 - Brolucizumab for treating neovascular age-related macular degeneration

T2 - An alternative for treatment-refractory patients

AU - Groen, Martin Biilmann

AU - Vestergaard, Anders Højslet

AU - Cehofski, Lasse Jørgensen

PY - 2025/1/21

Y1 - 2025/1/21

U2 - 10.1111/aos.17446

DO - 10.1111/aos.17446

M3 - Comment/debate

C2 - 39835444

AN - SCOPUS:85215538200

SN - 1755-375X

JO - Acta Ophthalmologica

JF - Acta Ophthalmologica

ER -